(Q54538613)

31 May 2018

title

Epidermal growth factor receptor gene mutation, amplification and protein expression in malignant pleural mesothelioma. (English)

1 reference

31 May 2018

author name string

K Okuda

1

1 reference

31 May 2018

H Sasaki

2

1 reference

31 May 2018

O Kawano

3

1 reference

31 May 2018

H Yukiue

4

1 reference

31 May 2018

T Yokoyama

5

1 reference

31 May 2018

M Yano

6

1 reference

31 May 2018

Y Fujii

7

1 reference

31 May 2018

publication date

8 April 2008

1 reference

31 May 2018

Journal of Cancer Research and Clinical Oncology

published in

1 reference

31 May 2018

volume

134

1 reference

31 May 2018

issue

10

1 reference

31 May 2018

page(s)

1105-1111

1 reference

31 May 2018

https://scigraph.springernature.com/pub.10.1007/s00432-008-0384-4

exact match

0 references

cites work

Malignant pleural mesothelioma and epidermal growth factor receptor (EGF-R). Relationship of EGF-R with histology and survival using fixed paraffin embedded tissue and the F4, monoclonal antibody

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00432-008-0384-4

Analysis of current trends in United States mesothelioma incidence

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00432-008-0384-4

Epidermal growth factor receptor gene and protein and gefitinib sensitivity in non-small-cell lung cancer

21 January 2018

1 reference

12 December 2020

The role of extrapleural pneumonectomy in malignant pleural mesothelioma. A Lung Cancer Study Group trial

1 reference

12 December 2020

The European mesothelioma epidemic

1 reference

12 December 2020

EGFR Mutation status in Japanese lung cancer patients: genotyping analysis using LightCycler

1 reference

12 December 2020

Clinico-pathological and biological prognostic factors in pleural malignant mesothelioma

1 reference

12 December 2020

Inhibition of epidermal growth factor receptor signaling in malignant pleural mesothelioma

1 reference

12 December 2020

Therapeutic targeting of multiple signaling pathways in malignant pleural mesothelioma

1 reference

12 December 2020

Epidermal growth factor receptor in non-small-cell lung carcinomas: correlation between gene copy number and protein expression and impact on prognosis.

1 reference

12 December 2020

Common EGFR mutations conferring sensitivity to gefitinib in lung adenocarcinoma are not prevalent in human malignant mesothelioma.

1 reference

12 December 2020

Erlotinib in lung cancer - molecular and clinical predictors of outcome

1 reference

12 December 2020

Epidermal growth factor receptor gene mutation in non-small cell lung cancer using highly sensitive and fast TaqMan PCR assay

1 reference

12 December 2020

Targeting the epidermal growth factor receptor in cancer: apoptosis takes center stage.

1 reference

12 December 2020

Transforming growth factor alpha and epidermal growth factor receptor in reactive and malignant mesothelial proliferations

1 reference

12 December 2020

Phase II study of erlotinib in patients with malignant pleural mesothelioma: a Southwest Oncology Group Study

1 reference

12 December 2020

EGFR and cancer prognosis

1 reference

12 December 2020

EGFR expression: associations with outcome and clinicopathological variables in malignant pleural mesothelioma

1 reference

12 December 2020

EGFR overexpression in malignant pleural mesothelioma

1 reference

12 December 2020

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy

1 reference

12 December 2020

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

1 reference

12 December 2020

Surgically debulked malignant pleural mesothelioma: results and prognostic factors.

1 reference

12 December 2020

EGFR and erbB2 mutation status in Japanese lung cancer patients

1 reference

12 December 2020

Increased epidermal growth factor receptor gene copy number detected by fluorescence in situ hybridization associates with increased sensitivity to gefitinib in patients with bronchioloalveolar carcinoma subtypes: a Southwest Oncology Group Study

1 reference

12 December 2020

Epidermal growth factor receptor signaling and the invasive phenotype of ovarian carcinoma cells

1 reference

12 December 2020

A novel approach in the treatment of cancer: targeting the epidermal growth factor receptor.

1 reference

12 December 2020

Continuing increase in mesothelioma mortality in Britain.

1 reference

12 December 2020

Gene copy number for epidermal growth factor receptor (EGFR) and clinical response to antiEGFR treatment in colorectal cancer: a cohort study

1 reference

12 December 2020

Gefitinib in patients with malignant mesothelioma: a phase II study by the Cancer and Leukemia Group B.

1 reference

12 December 2020

The selective epidermal growth factor receptor tyrosine kinase inhibitor PD153035 suppresses expression of prometastasis phenotypes in malignant pleural mesothelioma cells in vitro

1 reference

12 December 2020

Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma

1 reference

12 December 2020

10.1007/S00432-008-0384-4

Identifiers

DOI

1 reference

31 May 2018

release_56l5pbckmjarxpkwzzplh5ihwa

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/56l5pbckmjarxpkwzzplh5ihwa

24 November 2022

mapped directly with Wikidata item

1 reference

31 May 2018